Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: DEExchange: Nasdaq
DilutionScan read 42 of InflaRx N.V.'s SEC filings and found 1 warrant series, 1 ATM program, 2 shelf registrations and 1 completed offering on file for IFRX. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 3, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
GLSIGreenwich LifeSciences, Inc.
IMRXImmuneering Corporation
CABACabaletta Bio, Inc.
ABEOAbeona Therapeutics Inc.
FATEFate Therapeutics, Inc.
CAMPCAMP4 Therapeutics Corporation
OCGNOcugen, Inc.
LXEOLexeo Therapeutics, Inc. Common Stock
VNDAVanda Pharmaceuticals Inc.
LCTXLineage Cell Therapeutics, Inc.
QTTBQ32 Bio Inc.
LRMRLarimar Therapeutics, Inc.
KRROKorro Bio, Inc.
LYELLyell Immunopharma, Inc.
SLGLSol-Gel Technologies Ltd. Ordinary Shares